Mehul Mehta, MD, is the Chief Medical Officer at Albright Stonebridge Group, part of Dentons Global Advisors. As leader of the firm’s Health practice, he draws on decades of global healthcare, medical education, and life science research systems experience to advise and assist clients on the development and implementation of healthcare, education, and research systems in markets around the world while also providing healthcare inputs to ASG and its teams.
Previously, Dr. Mehta held distinguished leadership positions at Harvard Medical International and at Partners Healthcare International, where he oversaw global strategy, program development, and operations implementation in over 30 countries. At each, he worked to reform healthcare delivery systems and educational and research entities around the world, with an emphasis on building capacity, creating and implementing sustainable healthcare models, and building research systems. He also served as a Senior Fellow at the Harvard Global Health Institute, where he was the faculty lead on the technology and health initiative, specifically focused on AI in global health. He continues to be a member of the Department of Ophthalmology at Harvard Medical School, where he has been since 1997, and to be on the Honorary Clinical Staff at Massachusetts Eye & Ear in Boston.
Dr. Mehta completed medical school with honors at the University of Bombay in India, and his clinical training in retinal diseases at Harvard Medical School and Massachusetts Eye & Ear. He completed his post-doctoral research at the Schepens Eye Research Institute of Harvard Medical School. He also holds an M.A. in Cognitive and Neural Systems, focused on neural networks and AI, from Boston University.
Earlier in his career he was a consultant in the healthcare practice at McKinsey and Company. Dr. Mehta sits on the boards of non-profit health care entities and continues to teach and publish on global health. He is fluent in Hindi and other Indian languages.